Malignant pleural mesothelioma with brain metastasis

被引：0

作者：

Hurmuz, P. ^{[1
]}

Zorlu, F. ^{[1
]}

Cansiz, C. ^{[3
]}

Emri, S. ^{[2
]}

机构：

[1] Hacettepe Univ, Fac Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey

[2] Hacettepe Univ, Fac Med, Dept Chest Dis, TR-06100 Ankara, Turkey

[3] Ankara Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey

来源：

JOURNAL OF BUON | 2009年 / 14卷 / 01期

关键词：

brain metastasis; malignant pleural mesothelioma; TRIMODALITY THERAPY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Malignant pleural mesothelioma (MPM) is a rare neoplasm associated with poor prognosis. Local disease progression is the major cause of death rather than distant metastasis. Intracranial metastases are seen very rarely. Herein, we report a case of MPM with brain metastasis treated with cranial irradiation.

引用

页码：123 / 125

页数：3

共 9 条

[1]

Baldini EH, 1997, ANN THORAC SURG, V63, P334

[2]

FALCONIERI G, 1991, ARCH PATHOL LAB MED, V115, P591

[3] Presentation of malignant pleural mesothelioma with symptomatic brain metastasis: Report of a case [J].

Huncharek, M ;

Bseiso, A ;

Hutchins, L ;

Warner, J .

TUMORI, 2004, 90 (04) :424-427

[4]

Kitai Ryuhei, 1995, Neurologia Medico-Chirurgica, V35, P172, DOI 10.2176/nmc.35.172

[5]

PASS HI, 2001, CANC PRINCIPLES PRAC, P1937

[6] Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma [J].

Sterman, DH ;

Albelda, SM .

RESPIROLOGY, 2005, 10 (03) :266-283

[7] MESOTHELIOMA AND RADICAL MULTIMODALITY THERAPY - WHO BENEFITS [J].

SUGARBAKER, DJ ;

JAKLITSCH, MT ;

LIPTAY, MJ .

CHEST, 1995, 107 (06) :S345-S350

[8] Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients [J].

Sugarbaker, DJ ;

Flores, RM ;

Jaklitsch, MT ;

Richards, WG ;

Strauss, GM ;

Carson, JM ;

DeCamp, MM ;

Swanson, SJ ;

Bueno, R ;

Lukanich, JM ;

Baldini, EH ;

Mentzer, SJ .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (01) :54-63

[9] Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma [J].

Vogelzang, NJ ;

Rusthoven, JJ ;

Symanowski, J ;

Denham, C ;

Kaukel, E ;

Ruffie, P ;

Gatzemeier, U ;

Boyer, M ;

Emri, S ;

Manegold, C ;

Niyikiza, C ;

Paoletti, P .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2636-2644

← 1 →